Breast Lesions Clinical Trial
Official title:
A Prospective, Open Label, Post Marketing Study of Magseed and Sentimag in Patients Undergoing Surgical Excision of a Breast Lesion That Requires Preoperative Radiographic Localization
The purpose of this post-marketing study is to provide prospective evidence that the Magseed and Sentimag® is effective for lesion localization in patients undergoing surgical excision of a breast lesion and to summarize measures of product safety and performance.
This is a post-market, prospective, open label, single arm study of Magseed and Sentimag in patients undergoing surgical excision of a breast lesion. Subjects will have the Magseed marker deployed under imaging guidance up to thirty days prior to surgery. The Magseed marker will be localized using the Sentimag system during surgery and removed with the lesion. After the lumpectomy procedure, subjects will be evaluated for safety and patient reported outcomes. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03520127 -
A Registry Study Evaluating Outcomes in Breast Biopsy With the Intact™ Breast Lesion Excision System (BLES)
|
||
| Active, not recruiting |
NCT03706534 -
Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms
|
N/A | |
| Completed |
NCT00599105 -
Angiogenesis in Early Breast Cancer for Prognosis Prediction
|
N/A | |
| Recruiting |
NCT01368939 -
Investigation of High Resolution Nuclear Breast Imaging Camera (MBI) in Patients Administered Tc-99m Sestamibi (ROSE)
|
N/A | |
| Terminated |
NCT00934297 -
Visualization Tool for Investigation of Breast Lesions
|
N/A | |
| Unknown status |
NCT00671385 -
Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning
|
N/A | |
| Recruiting |
NCT05118295 -
Single Step Lesion Annotation and Localization of Suspicious Breast Lesions
|
Early Phase 1 |